Tofacitinib in AxSpA in Developing Countries Save
Dr. Antoni Chan reports on abstracts 0582 (Long-Term Efficacy and Safety of Tofacitinib in Active Axial Spondyloarthritis: Experience from a Tertiary Care Center in South India) and abstract 0554 (Real world experience with generic Tofacitinib in Axial Spondyloarthritis from North India) presented at the 2025 ACR Convergence meeting in Chicago.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.